KBU2046
Product Specifications
UNSPSC Description
KBU2046 is an oral, highly selective inhibitor of cell motility and cell invasion in vitro. KBU2046 binds chaperone heterocomplexes, selectively alters binding of client proteins that regulate motility, and lacks all of the hallmarks of classical HSP90 inhibitors. KBU2046 inhibits cancer metastasis and prolongs life[1].
Target Antigen
HSP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Metabolic Enzyme/Protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kbu2046.html
Purity
99.52
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C1C(C2=CC=C(F)C=C2)COC3=CC=CC=C13
Molecular Weight
242.25
References & Citations
[1]Xu L, et al. Precision therapeutic targeting of human cancer cell motility. Nat Commun. 2018 Jun 22;9(1):2454.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-120548/KBU2046-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-120548/KBU2046-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
1143863-69-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1136166 Inquire
Recombinant Burkholderia cenocepacia 4-hydroxybenzoate octaprenyltransferase (ubiA)
Ask
View Details 
MBS7079443-01 0.05 mg (E-Coli)
Recombinant Notechis scutatus scutatus Natriuretic peptide NsNP-a
Ask
View Details MBS7079443-02 0.2 mg (E-Coli)
Recombinant Notechis scutatus scutatus Natriuretic peptide NsNP-a
Ask
View Details